Dipòsit Digital de Documents de la UAB 1,781 registres trobats  anterior11 - 20següentfinal  anar al registre: La cerca s'ha fet en 0.02 segons. 
11.
8 p, 6.1 MB Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization / Klaska, I.P. (Guy's Hospital, Great Maze Pond, London, UK) ; White, Anne (University of Manchester, UK) ; Villacampa, Pilar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hoke, Justin (University College London, UK) ; Abelleira-Hervas, Laura (University College London, UK) ; Maswood, Ryea N. (University College London, UK) ; Ali, Robin R. (Guy's Hospital, Great Maze Pond, London, UK) ; Bunce, Catey (King's College London, Addison House, London, UK) ; Unwin, Richard D. (University of Manchester, UK) ; Cooper, Garth J.S. (University of Manchester, UK) ; Bishop, Paul N. (Manchester University NHS Foundation Trust, UK) ; Bainbridge, James W. (University College London, UK)
Opticin is an extracellular glycoprotein present in the vitreous. Its antiangiogenic properties offer the potential for therapeutic intervention in conditions such as proliferative diabetic retinopathy and retinopathy of prematurity. [...]
2022 - 10.1016/j.exer.2021.108908
Experimental Eye Research, Vol. 215 (february 2022)  
12.
9 p, 442.2 KB B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy / Woyach, Jennifer A. (The Ohio State University Comprehensive Cancer Center, Columbus, Ohio) ; Ghia, Paolo (Universita Vita-Salute San Raffaele, Milan, Italy) ; Byrd, John C. (University of Cincinnati College of Medicine, Cincinnati, Ohio) ; Ahn, Inhye E. (Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland) ; Moreno, Carol (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Brien, Susan M. (UC Irvine. Chao Family Comprehensive Cancer Center, Irvine, California) ; Jones, Daniel (The Ohio State University Comprehensive Cancer Center, Irvine, California) ; Cheung, Leo W.K. (Pharmacyclics LLC, an AbbVie Company, South San Francisco, California) ; Chong, Elizabeth (Pharmacyclics LLC, an AbbVie Company, South San Francisco, California) ; Kwei, Kevin (Pharmacyclics LLC, an AbbVie Company, South San Francisco, California) ; Dean, James P. (Pharmacyclics LLC, an AbbVie Company, South San Francisco, California) ; James, Dannelle F. (Pharmacyclics LLC, an AbbVie Company, South San Francisco, California) ; Wiestner, Adrian (Laboratory of Lymphoid Malignancies, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland)
Purpose: Acquired mutations in Bruton's tyrosine kinase (BTK) or phospholipase C-γ2 (PLCG2) genes are associated with clinical progressive disease (PD) in patients with chronic lymphocytic leukemia (CLL) treated with BTK inhibitors. [...]
2023 - 10.1158/1078-0432.CCR-22-3887
Clinical Cancer Research, Vol. 29 Núm. 16 (august 2023) , p. 3065-3073  
13.
14 p, 1.6 MB Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers / Blanco, Belén (Red Española de Terapias Avanzadas (TERAV)) ; Ramírez-Fernández, Ángel (Immuno-Oncology and Immunotherapy Group. Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Argemí-Muntadas, Lidia (Aarhus University, Denmark) ; Fuentes, Patricia (Centro de Biología Molecular Severo Ochoa CSIC-UAM) ; Aguilar-Sopeña, Óscar (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Gutierrez-Agüera, Francisco (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zanetti, Samanta Romina (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tapia-Galisteo, Antonio (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Díez-Alonso, Laura (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Segura-Tudela, Alejandro (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Castellá, Maria (Hospital Clínic i Provincial de Barcelona) ; Marzal, Berta (Hospital Clínic i Provincial de Barcelona) ; Betriu-Méndez, Sergi (Hospital Clínic i Provincial de Barcelona) ; Harwood, Seandean L. (Aarhus University, Denmark) ; Compte, Marta (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Lykkemark, Simon (Aarhus University, Denmark) ; Erce-Llamazares, Ainhoa (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Rubio-Pérez, Laura (Universidad Francisco de Vitoria (UFV). Pozuelo de Alarcón) ; Jiménez-Reinoso, Anaïs (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Domínguez-Alonso, Carmen (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Neves, Maria (Centro de Biología Molecular Severo Ochoa CSIC-UAM) ; Morales, Pablo (Hospital 12 de Octubre (Madrid)) ; Paz-Artal, Estela (Department of Immunology Ophthalmology and ENT. School of Medicine. Universidad Complutense) ; Guedan, Sonia (Hospital Clínic i Provincial de Barcelona) ; Sanz, Laura (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Toribio, Maria L. (Centro de Biología Molecular Severo Ochoa CSIC-UAM) ; Roda-Navarro, Pedro (Instituto de Investigación Sanitaria 12 de Octubre (imas12)) ; Juan, Manel (Hospital Clínic i Provincial de Barcelona) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Álvarez-Vallina, Luis (Hospital 12 de Octubre (Madrid))
Chimeric antigen receptor (CAR)-modified T cells have revolutionized the treatment of CD19-positive hematologic malignancies. Although anti-CD19 CAR-engineered autologous T cells can induce remission in patients with B-cell acute lymphoblastic leukemia, a large subset relapse, most of them with CD19-positive disease. [...]
2022 - 10.1158/2326-6066.CIR-21-0853
Cancer Immunology Research, Vol. 10 Núm. 4 (april 2022) , p. 498-511  
14.
19 p, 8.1 MB Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin / Franco Valls, Héctor (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Tusquets Uxó, Elsa (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Sala, Laura (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Val, Maria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Peña, Raúl (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Iaconcig, Alessandra (International Centre for Genetic Engineering and Biotechnology (ICGEB)) ; Villarino, Álvaro (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Jiménez Arriola, Martín (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Massó, Pere (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Trincado Alonso, Juan Luis, 1987- (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Eyras, Eduardo (John Curtin School of Medical Research. Australian National University) ; Muro, Andrés F. (International Centre for Genetic Engineering and Biotechnology (ICGEB)) ; Otero, Jorge (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Garcia de Herreros, Antonio (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM)) ; Baulida, Josep (Programa de Recerca en Càncer. Hospital del Mar Research Institute (IMIM))
Background: As in most solid cancers, the emergence of cells with oncogenic mutations in the mammary epithelium alters the tissue homeostasis. Some soluble factors, such as TGFβ, potently modify the behavior of healthy stromal cells. [...]
2023 - 10.1186/s13058-023-01736-y
Breast cancer research, Vol. 25 Núm. 1 (december 2023) , p. 143  
15.
10 p, 1.7 MB Cuff-based oscillometric central and brachial blood pressures obtained through ABPM are similarly associated with renal organ damage in arterial hypertension / Fernandez-Llama, Patricia (Institut d'Investigació Biomèdica Sant Pau) ; Pareja, Júlia (Hospital Universitari MútuaTerrassa) ; Yun, Sergi (Hospital Universitari MútuaTerrassa) ; Vázquez, Susana (Hospital del Mar (Barcelona, Catalunya)) ; Oliveras, Anna (Hospital del Mar (Barcelona, Catalunya)) ; Armario, Pedro (Hospital Moisès Broggi) ; Blanch, Pedro (Hospital Moisès Broggi) ; Calero, Francesca (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Sierra, Cristina (Hospital Clínic i Provincial de Barcelona) ; De La Sierra, Alejandro (Hospital Universitari MútuaTerrassa) ; Universitat Autònoma de Barcelona
Central blood pressure (BP) has been suggested to be a better estimator of hypertension-associated risks. We aimed to evaluate the association of 24-hour central BP, in comparison with 24-hour peripheral BP, with the presence of renal organ damage in hypertensive patients. [...]
2017 - 10.1159/000485595
Kidney & blood pressure research, Vol. 42 Núm. 6 (2017) , p. 1068-1077  
16.
8 p, 892.9 KB Validation of 'POIBA-how do we eat?' questionnaire in 9-10 years old schoolchildren / Ariza, Carles (Institut d'Investigació Biomèdica Sant Pau) ; Arechavala, Teresa (Ciber de Epidemiología y Salud Pública (CIBERESP)) ; Valmayor, Sara (Agència de Salut Pública de Barcelona) ; Serral, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Moncada, A. (Ajuntament de Terrassa) ; Rajmil, Luis (Hospital del Mar (Barcelona, Catalunya)) ; Schiaffino, A. (Institut Català d'Oncologia) ; Sánchez-Martínez, Francesca (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
It is difficult to obtain good food reports with Food Frequency Questionnaires (FFQ) among children. In addition, validated questionnaires are scarce. The aim of this study was to validate the 'POIBA-How do we eat?' (POIBA-HDWE) FFQ and whether it could be administered to children under 10 years of age. [...]
2017 - 10.1080/16546628.2017.1391665
Food and Nutrition Research, Vol. 61 (2017) , p. 1391665  
17.
14 p, 563.4 KB Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors : The necessity of repeated molecular analysis / González-Larriba, José Luis (Hospital Universitario Clínico San Carlos (Madrid)) ; Lázaro-Quintela, Martín (Complexo Hospitalario Universitario de Vigo) ; Cobo, Manuel (Hospital Regional Universitario de Málaga) ; Dómine, Manuel (Hospital Universitario Fundación Jiménez Díaz) ; Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ; García-Campelo, Rosario (Hospital Universitario de A Coruña) ; Universitat Autònoma de Barcelona
One of the most important advances in the treatment of non-small cell lung cancer (NSCLC) has been the identification of molecular alterations vulnerable to targeted inhibition, such as mutations in the epidermal growth factor receptor (EGFR) gene. [...]
2017 - 10.21037/tlcr.2017.10.03
Translational Lung Cancer Research, Vol. 6 (january 2017) , p. S21-S34  
18.
4 p, 334.8 KB Asthma-COPD overlap is not a homogeneous disorder : Further supporting data / Pérez-de-Llano, Luis (Hospital Universitario Lucus Augusti (Lugo)) ; Cosio, Borja G. (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; Iglesias, Amanda (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ; de las Cuevas, Natividad (Hospital 12 de Octubre (Madrid)) ; Soler-Cataluña, Juan Jose (Hospital Arnau de Vilanova (València)) ; Izquierdo, Jose Luis (Hospital Universitario de Guadalajara) ; López-Campos, Jose Luis (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Calero, Carmen (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Plaza, Vicente (Institut d'Investigació Biomèdica Sant Pau) ; Miravitlles, Marc (Hospital Universitari Vall d'Hebron) ; Torrego, Alfons (Institut d'Investigació Biomèdica Sant Pau) ; Moragón, Eva Martínez (Hospital Universitari Doctor Peset (València)) ; Soriano, Joan B. (Universidad Autónoma de Madrid) ; Viña, Antolin Lopez (Hospital Puerta de Hierro (Madrid)) ; Bobolea, Irina (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
Asthma-COPD ovelap (ACO) is an umbrella term that encompasses patients with COPD and eosinophilic inflammation (e-COPD) and smoking asthmatics with non-fully reversible airflow obstruction (SA). We compared the clinical characteristics and the inflammatory profile of e-COPD and SA. [...]
2017 - 10.1186/s12931-017-0667-x
Respiratory Research, Vol. 18 Núm. 1 (february 2017) , p. 183  
19.
5 p, 1.0 MB Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS) / Kuebler, Bernd (Centre de Medicina Regenerativa de Barcelona (CMRB)) ; Aran, Begoña (Centre de Medicina Regenerativa de Barcelona (CMRB)) ; Miquel-Serra, Laia (Centre de Medicina Regenerativa de Barcelona (CMRB)) ; Muñoz, Yolanda (Centre de Medicina Regenerativa de Barcelona (CMRB)) ; Ars, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Bullich Vilanova, Gemma (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Furlano, Monica (Institut d'Investigació Biomèdica Sant Pau) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Marti, Merce (Centre de Medicina Regenerativa de Barcelona (CMRB)) ; Veiga, Anna (Centre de Medicina Regenerativa de Barcelona (CMRB)) ; Raya, Ángel (Institució Catalana de Recerca i Estudis Avançats) ; Universitat Autònoma de Barcelona
A skin biopsy was obtained from a 25-year-old female patient with autosomal recessive Alport syndrome (ARAS) with the homozygous COL4A3 mutation c. 345delG, p. (P166Lfs*37). Dermal fibroblasts were derived and reprogrammed by nucleofection with episomal plasmids carrying OCT3/4, SOX2, KLF4 LIN28, L-MYC and p53shRNA. [...]
2017 - 10.1016/j.scr.2017.08.021
Stem Cell Research, Vol. 25 (december 2017) , p. 1-5  
20.
26 p, 5.7 MB Influence of social determinants, lifestyle, emotional well-being and the use of unconventional therapies in breast cancer progression in a cohort of women in Barcelona : Protocol for the DAMA Cohort / Puigpinós i Riera, Rosa (Institut d'Investigació Biomèdica Sant Pau) ; Continente, Xavier (Institut d'Investigació Biomèdica Sant Pau) ; Serral, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Bargalló, Xavi (Universitat de Barcelona) ; Doménech, Montserrat (Association of Women with Breast Cancer (Agata)) ; Espinosa-Bravo, Martín (Hospital Universitari Vall d'Hebron) ; Grau, Jaume (Universitat de Barcelona) ; Macià, Francesc (Institut Hospital Del Mar d'Investigació Mèdica) ; Manzanera, Rafael (MC Mutual) ; Pla i Consuegra, Margarida (Universitat de Barcelona) ; Quintana Ruiz, Maria Jesús (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Maria (Institut Municipal d'Investigacions Mèdiques) ; Vidal, Eulalia (Universitat Ramon Llull) ; Universitat Autònoma de Barcelona
Breast cancer continues to be the most commonly diagnosed cancer in women. Breast cancer survivors face numerous problems, especially after completing the first year of intense treatment. We present the protocol for an ongoing study to analyze the impact of a series of factors on breast cancer survival related to lifestyle, emotional well-being, and use of complementary and alternative medicine (CAM). [...]
2017 - 10.2196/resprot.7653
JMIR Research Protocols, Vol. 6 Núm. 12 (december 2017) , p. e249  

Dipòsit Digital de Documents de la UAB : 1,781 registres trobats   anterior11 - 20següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.